$2.500
-0.124 (-4.94%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
LIMN Prediction & Forecast by Similar Chart Analysis
Alphio's LIMN stock price prediction model matches the current Liminatus Pharma Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.47 (-1.33%). The 1-week path is $2.56 (+2.27%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Liminatus Pharma Inc Stock?
Liminatus Pharma Inc is not a good buy right now due to its significant financial losses and poor technical indicators. The current price is $2.50, which is 92.20% lower than its year-to-date performance. The RSI is at 29.815, indicating that the stock is oversold, but this is not sufficient to justify a buy given the overall financial health. The company has a forward P/E ratio of 0, suggesting no earnings growth expectations, and a gross margin of 0%, indicating no profitability. The main risk is the company's high debt-to-equity ratio of 479.85%, which poses a significant financial risk.
LIMN stock price ended at $2.50 on Friday, after losing -4.94%
Liminatus Pharma Inc (LIMN) last closed at $2.5, losing -4.94%. These facts feed the 1-day and 1-week LIMN price prediction above.
Forecast Drivers
Liminatus Pharma Inc (LIMN) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches LIMN, ranked by similarity.
Seasonality analysis for LIMN
Historically the probability of a positive November return for LIMN is 45.45%. January offers the highest probability of a positive month at 57.38%, while September is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for LIMN
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Nov 2026 | $5.74 | $6.00 | $6.35 | +139.96% |
| Dec 2026 | $5.09 | $5.21 | $5.42 | +108.36% |
In 2026, Liminatus Pharma Inc (LIMN) is projected to range from $5.09 to $6.35.
Liminatus Pharma Inc 2026 monthly forecast
In Nov 2026, Liminatus Pharma Inc is projected to average $6.00, with a low of $5.74 and high of $6.35.
In Dec 2026, Liminatus Pharma Inc is projected to average $5.21, with a low of $5.09 and high of $5.42.
Related articles
- Are You Buying NVIDIA’s Earnings or Its CEO’s Perfect Image?An Alphio analysis of NVIDIA’s share-price timeline, operating results, governance uncertainty and upcoming earnings.
- Stock Market After the 2026 Midterms: What a Democratic Congress Means for InvestorsDemocrats swept Congress in the 2026 midterms. See how stocks reacted, what history says about post-midterm returns, and which sectors face new risks.
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.